📣 VC round data is live. Check it out!

Lotte Valuation Multiples

Discover revenue and EBITDA valuation multiples for Lotte and similar public comparables like J&J Snack Foods, M. Dias Branco, Dole, Italmobiliare and more.

Lotte Overview

About Lotte

Lotte Corp formerly, Lotte Confectionery Co Ltd is a Korea-based company engaged in the food business. The company manufactures and distributes confectionery products such as gum, chocolate, biscuit, ice cream, pie, snacks, and candy, among others. The company distributes its products through retail stores, supermarkets, and other distribution channels.


Founded

1967

HQ

South Korea

Employees

N/A

Financials (FY)

Revenue: $11B
EBITDA: $607M

EV

$6B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Lotte Financials

Lotte reported last fiscal year revenue of $11B and EBITDA of $607M.

In the same fiscal year, Lotte generated $3B in gross profit, $607M in EBITDA, and had net loss of ($443M).


Lotte P&L

In the most recent fiscal year, Lotte reported revenue of $11B and EBITDA of $607M.

Lotte is unprofitable as of last fiscal year, with gross margin of 29%, EBITDA margin of 6%, and net margin of (4%).

See analyst estimates for Lotte
Last FY202320242025202620272028
Revenue$11B$10B$11B$11B
Gross Profit$3B$3B$3B$3B
Gross Margin29%29%29%29%
EBITDA$607M$1B$329M$607M
EBITDA Margin6%10%3%6%
EBIT Margin2%3%2%2%
Net Profit($443M)($11M)($697M)($443M)
Net Margin(4%)(0%)(6%)(4%)
Net Debt$5B

Financial data powered by Morningstar, Inc.

Lotte Stock Performance

Lotte has current market cap of $1B, and enterprise value of $6B.


Lotte's stock price is $20.02.

Lotte has an EPS (earnings per share) of $-6.20.

See more trading valuation data for Lotte
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$6B$1B-0.4%$-6.20

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Lotte Valuation Multiples

Lotte trades at 0.6x EV/Revenue multiple, and 10.4x EV/EBITDA.

See NTM and 2027E valuation multiples for Lotte

Lotte Financial Valuation Multiples

As of May 10, 2026, Lotte has market cap of $1B and EV of $6B.

Lotte has a P/E ratio of (3.2x).

Last FY202320242025202620272028
EV/Revenue0.6x0.6x0.6x0.6x
EV/EBITDA10.4x6.0x19.2x10.4x
EV/EBIT38.4x18.6x26.7x38.4x
EV/Gross Profit2.1x2.1x2.0x2.1x
P/E(3.2x)(136.2x)(2.1x)(3.2x)
EV/FCF(44.1x)21.4x(28.5x)(44.1x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Lotte Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Lotte Margins & Growth Rates

In the most recent fiscal year, Lotte reported gross margin of 29%, EBITDA margin of 6%, and net margin of (4%).

See estimated margins and future growth rates for Lotte

Lotte Margins

Last FY20242025202720282029
Gross Margin29%29%29%
EBITDA Margin6%3%6%
EBIT Margin2%2%2%
Net Margin(4%)(6%)(4%)
FCF Margin(1%)(2%)(1%)

Lotte Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth4%(1%)
Gross Profit Growth3%(3%)
EBITDA Growth(69%)85%
EBIT Growth(30%)(30%)
Net Profit Growth6534%(36%)
FCF Growth(175%)(35%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Lotte Operational KPIs

Access forward-looking KPIs for Lotte
Last FY202320242025202620272028
S&M Expenses to Revenue11%11%11%11%
G&A Expenses to Revenue1%1%1%1%
R&D Expenses to Revenue0%0%0%0%
Opex to Revenue27%26%27%27%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Lotte Competitors

Lotte competitors include J&J Snack Foods, M. Dias Branco, Dole, Italmobiliare, Bell Food Group, Herbalife, Osotspa, Grupo Kuo, Cobram Estate Olives and Betagro.

Most Lotte public comparables operate across Food & Beverages.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
J&J Snack Foods1.0x1.0x8.6x8.6x
M. Dias Branco0.7x0.7x5.3x6.0x
Dole0.3x0.3x6.9x6.0x
Italmobiliare2.1x1.9x7.3x8.6x
Bell Food Group0.4x0.4x5.3x5.3x
Herbalife0.6x0.6x5.3x4.8x
Osotspa1.5x1.5x6.6x6.9x
Grupo Kuo0.6x0.6x6.3x5.9x

This data is available for Pro users. Sign up to see all Lotte competitors and their valuation data.

Start Free Trial

Lotte M&A Activity

Lotte has acquired 1 company to date.

Last acquisition by Lotte was on October 24th 2018. Lotte acquired L&M Mayson for $86M (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by Lotte

L&M Mayson
Description
L&M Mayson is a Myanmar-based bakery operating three plants producing bread, cookies, and pies. The company distributes through 12 retail outlets and 10 logistics centers nationwide, holding the largest market share in packaged baked goods. Sales reached 35 billion kyats last year from popular items like cream buns and layer cakes. Established in Yangon, L&M Mayson sources flour locally for daily production exceeding 100,000 units.
HQ CountryMyanmar
HQ City
Yangon
Deal Date24 Oct 2018
Valuation$86M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Lotte acquisitions and their M&A valuation multiples.

Start Free Trial

Lotte Investment Activity

Lotte has invested in 8 companies to date.

Latest investment by Lotte was on April 21st 2023. Lotte invested in Pinot Bio in their $10M Series A round (EV/Revenue multiple of ).

See VC round multiples

Latest Investments by Lotte

Pinot Bio
Syzygy Plasmonics
Neubility
FOOD Assemble
Description
Pinot Bio is a Seoul-headquartered biotechnology company engineering novel anticancer therapeutics targeting tumor microenvironments and immune checkpoints. Its pipeline features bispecific antibodies and PROTACs advancing through preclinical stages for solid tumors including lung and breast cancers. The firm collaborates with Korean research institutes on IND filings and early clinical trials.
Syzygy Plasmonics is a Houston-based developer of photocatalytic reactors for hydrogen production. Its light-powered technology operates at temperatures over 1,000°F lower than traditional methods, enabling on-site green hydrogen generation for fuel cell vehicles and small industrial sites with rapid start-stop capabilities and reduced maintenance.
Neubility is a Seoul-based robotics company founded in 2017 that deploys self-driving delivery robots equipped with vision-based localization technology for urban parcel services. It conducts operations in high-density Asian cities handling frequent daily deliveries.
FOOD Assemble is a Busan-based food delivery platform serving South Korea's urban areas. The service partners with local restaurants to deliver Korean staples like bibimbap, kimbap, and noodles via dedicated riders. Launched in 2019, FOOD Assemble covers Busan, Ulsan, and Gyeongnam Province with real-time tracking and contactless options.
HQ CountrySouth KoreaUnited StatesSouth KoreaSouth Korea
HQ City
Suwon
Houston, TX
Seoul
Busan
Deal Date21 Apr 202316 Nov 202227 Apr 202211 Apr 2022
RoundSeries ASeries CSeries ASeries B
Raised$10M$76M$21M$8M
InvestorsAhn-Gook Pharmaceutical; BNH Investment; IMM Investment; KB Investment; LOTTE Biologics; Lotte Group; Quad Asset Management; Union Investment PartnersCarbon Direct Capital; Chevron Technology Ventures; Equinor Ventures; Evok Innovations; GOOSE Capital; Horizons Ventures; Lotte Group; Pan American Energy; Saudi Aramco Energy Ventures; Sumitomo Corporation of America; The Engine; Toyota VenturesCapstone Partners; FuturePlay; IMM Investment; KB Investment; Lotte Group; Samsung C&T; Shinhan Capital; SHINSEGAE INFORMATION; Signite PartnersInnopolis Partners; Lotte Group
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Lotte investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Lotte

When was Lotte founded?Lotte was founded in 1967.
Where is Lotte headquartered?Lotte is headquartered in South Korea.
Is Lotte publicly listed?Yes, Lotte is a public company listed on Korea Exchange.
What is the stock symbol of Lotte?Lotte trades under 004990 ticker.
When did Lotte go public?Lotte went public in 1974.
Who are competitors of Lotte?Lotte main competitors include J&J Snack Foods, M. Dias Branco, Dole, Italmobiliare, Bell Food Group, Herbalife, Osotspa, Grupo Kuo, Cobram Estate Olives, Betagro.
What is the current market cap of Lotte?Lotte's current market cap is $1B.
What is the current revenue of Lotte?Lotte's last fiscal year revenue is $11B.
What is the current EV/Revenue multiple of Lotte?Current revenue multiple of Lotte is 0.6x.
Is Lotte profitable?No, Lotte is not profitable.
How many companies Lotte has acquired to date?As of May 2026, Lotte has acquired 1 company.
What was the largest acquisition by Lotte?$86M acquisition of L&M Mayson on 24th October 2018 was the largest M&A Lotte has done to date.
What companies Lotte acquired?Lotte acquired L&M Mayson.
In how many companies Lotte has invested to date?As of May 2026, Lotte has invested in 8 companies.
What was the last Lotte investment?On 21st April 2023 Lotte invested in Pinot Bio, participating in a $10M Series A round, alongside Ahn-Gook Pharmaceutical, BNH Investment, IMM Investment, KB Investment, LOTTE Biologics, Lotte Group, Quad Asset Management, and Union Investment Partners.
In what companies Lotte invested in?Lotte invested in Wadiz, Syzygy Plasmonics, Standard Energy, Neubility, Rael, S2W, Pinot Bio, and FOOD Assemble.

See public comps similar to Lotte

Lists including Lotte

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial